Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling and simulation of pathways in menopause.

Dimitra Tsavachidou1, Michael N Liebman

  • 1Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, USA.

Journal of the American Medical Informatics Association : JAMIA
|September 12, 2002
PubMed
Summary

This study models menopause using estrogen production pathways to predict individualized risks for postmenopausal disorders. Simulations using UltraSAN align with experimental data, aiding in understanding genetic and environmental risk factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy Outcomes among Pregnant Persons after COVID-19 Vaccination: Assessing Vaccine Safety in Retrospective Cohort Analysis of U.S. National COVID Cohort Collaborative (N3C).

Vaccines·2024
Same author

Who is pregnant? Defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C).

JAMIA open·2023
Same author

Who is pregnant? defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C).

medRxiv : the preprint server for health sciences·2022
Same author

Advancing nonclinical innovation and safety in pharmaceutical testing.

Drug discovery today·2018
Same author

A clarion call to the community of current and potential journal reviewers.

Journal of translational medicine·2018
Same author

Personalized medicine: a perspective on the patient, disease and causal diagnostics.

Personalized medicine·2018

Area of Science:

  • Computational biology
  • Endocrinology
  • Genetics

Background:

  • Understanding menopause and its associated health risks is crucial for personalized medicine.
  • Complex molecular pathways, like estrogen production, influence physiological and pathological processes.

Purpose of the Study:

  • To model menopause processes for stratifying women by genotypic and environmental risk factors.
  • To assess individualized risks for postmenopausal disorders such as cancers, cardiovascular disease, and osteoporosis.

Main Methods:

  • Utilized the UltraSAN package for pathway analysis of estrogen production.
  • Incorporated detailed hormonal factors and experimental data from the female reproductive cycle.
  • Simulated hormone levels and validated against published experimental data.

Related Experiment Videos

Main Results:

  • The estrogen production model demonstrated good agreement with experimental data (typically < 2 ng/ml or 2 pg/ml for progesterone and estradiol).
  • The model allows for the integration of genetic variations, such as Single Nucleotide Polymorphisms (SNPs), affecting enzyme activity.

Conclusions:

  • The developed model provides a framework for analyzing menopause-related hormonal changes.
  • This approach can help elucidate the impact of genetic factors (e.g., aromatase SNPs) on hormone levels and associated health risks.